Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (27)

2022

  1. IX international curse of continuing formation in haemophilia and other congenital coagulopathies. The role of the Laboratory in coagulation disorders. Diagnosis of von Willebrand disease

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, Vol. 33, pp. S12-S14

2021

  1. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project

    Haemophilia, Vol. 27, Núm. 6, pp. 1007-1021

2011

  1. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease

    Haemophilia

  2. Focusing on haemophilia B: Prophylaxis in Spanish patients

    Haemophilia

  3. Prophylaxis therapy in haemophilia A: Current situation in Spain

    Haemophilia, Vol. 17, Núm. 1, pp. 75-80

2009

  1. Autosomal dominant von willebrand disease type 2M

    Acta Haematologica, Vol. 121, Núm. 2-3, pp. 139-144

  2. Haemophilia in Spain

    Haemophilia, Vol. 15, Núm. 3, pp. 665-675

  3. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease

    Blood Coagulation and Fibrinolysis, Vol. 20, Núm. 2, pp. 89-100

2008

  1. Consensus opinion for the selection and use of therapeutic products for the treatment of haemophilia in Spain

    Blood Coagulation and Fibrinolysis, Vol. 19, Núm. 5, pp. 333-340

  2. Type 2M von Willebrand disease: A variant of type 2A? [3]

    Journal of Thrombosis and Haemostasis

2007

  1. Lessons about recombinant activated factor VII. Ten years since its registration for use in hemophilia with inhibitor

    Medicina Clinica, Vol. 129, Núm. 10, pp. 382-386

  2. von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: A prospective multicenter trial in elective surgery

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 7, pp. 1420-1430

2005

  1. Psychometric field study of the new haemophilia quality of life questionnaire for adults: The 'Hemofilia-QoL'

    Haemophilia, Vol. 11, Núm. 6, pp. 603-610

  2. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 12, pp. 2619-2626

  3. Von Willebrand disease R1374C: Type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)

    American Journal of Hematology, Vol. 80, Núm. 3, pp. 188-196

2004

  1. C1272S: A New Candidate Mutation in Type 2A von Willebrand Disease That Disrupts the Disulfide Loop Responsible for the Interaction of VWF with Platelet GP Ib-IX

    American Journal of Hematology, Vol. 75, Núm. 2, pp. 73-77

  2. Development of a new disease-specific quality-of-life questionnaire to adults living with haemophilia

    Haemophilia, Vol. 10, Núm. 4, pp. 376-382

2002

  1. Advances in the therapy of von Willebrand disease

    Haemophilia, Vol. 8, Núm. 3, pp. 301-307

1999

  1. Importancia del estudio del factor v leiden y del alelo 29210a del gen de la protrombina en la enfermedad tromboembólica

    Sangre, Vol. 44, Núm. 1, pp. 3-6

1997

  1. Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction

    Annals of Hematology, Vol. 75, Núm. 3, pp. 111-115